User:Mac: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 9: | Line 9: | ||
* re-read biotech section in april ICP report; discuss w/ Carol | * re-read biotech section in april ICP report; discuss w/ Carol | ||
== Experts == | == [[User:Mac/Experts|Experts]] == | ||
* Jason Bobe | * Jason Bobe | ||
* Jason Kelly? | * Jason Kelly? | ||
* Jim Hardy | |||
* Mark Redmond (via LinkedIn) | |||
== Done == | == Done == |
Revision as of 12:46, 26 August 2009
I am characterizing the R&D process that brings diagnostic kits to market with a particular focus on which steps involve patent (or other IP) activity.
I keep notes real-time in Evernote and then transfer them to the wiki. You can view my ICP evernote collection here
current goals
Publish report about Commons-based activity in Diagnostic Kit Sector by end of September
- touch base on Monday w/ Carol
- work on skeleton of paper, meet to lay it out next Thursday (sept 3) morning
- re-read biotech section in april ICP report; discuss w/ Carol
Experts
- Jason Bobe
- Jason Kelly?
- Jim Hardy
- Mark Redmond (via LinkedIn)
Done
- articulate research question to solicit insight from experts: http://etherpad.com/mmuk9g1Y0A
- Asked Joseph Jackson
- Asked Jim Hardy
research agenda
Mac: focus on technology of kits
(first look at developmental process, then we will analyze access to the kit)
- What is a diagnostic kit?
- Where are kits sold, to whom, for what?
- Diagnose a disease; predict a disease; Direct-to-Consumer kits
- What are the inputs needed to develop a kit?
- What is the development process / value chain that leads to a clinical diagnostic kit?
- Aare there commons-based models active anywhere along the kit development pipeline (w/ andrew)
Andrew talks about patents
Andrew there Thurs & Fri: Just enumerating the patents that might pertain to diagnostics is hard:
- multiple databases
- classification scheme for scope of protection
- Carol: "we know duke team behind oft-used duke patent database; we can get in touch with them"